Profound Medical stock surges 20% on raised Q3 revenue outlook
Shares of Profound Medical Corp (NASDAQ:PROF) skyrocketed nearly 20% in after-hours trading on Wednesday after the medical device company announced an ambitious third quarter 2026 revenue forecast that surpassed Wall Street projections by about 45% to 47%. The company now anticipates generating between $9.8 million and $10.0 million in revenue for the quarter, a substantial 85% to 89% increase year-over-year from $5.3 million in Q3 2025.
Analysts had expected $6.78 million in revenue. Profound Medical CEO and Chairman Arun Menawat attributed the surge to strong commercial activity across the company's existing customer base and the acquisition of new clients. The company's projected revenue growth is even more impressive on a sequential basis, with revenue expected to jump an astounding 292% to 300% compared to $2.5 million in the second quarter of 2026.
Menawat emphasized that the projected earnings mark a significant milestone for Profound, highlighting the growing momentum behind the company's innovative interventional MRI procedures.
Rewritten by urgent.news; may contain errors — check the original.
This story
This is one outlet's version. Read the fullest account.
- Why is Profound Medical stock surging today? investing.com